Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GLP-1 Fc fusion protein
- Development stage
- Preclinical
- Lead developer
- Shandong Huabo Kaisheng Biotechnology
- Modality
- Peptides, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
GLP-1 Fc fusion protein (also referred to as GLP-1-Fc) is a preclinical-stage biologic drug being developed by Shandong Huabo Kaisheng Biotechnology. It is a recombinant fusion protein consisting of a glucagon-like peptide-1 (GLP-1) moiety fused to the Fc region of an immunoglobulin. This design is intended to extend the molecule's half-life relative to native GLP-1, allowing for less frequent administration. The drug acts as an agonist of the glucagon-like peptide 1 receptor (GLP-1R), activating the receptor to enhance glucose-dependent insulin secretion and to regulate appetite and gastric emptying. It is currently under investigation for the treatment of metabolic diseases, primarily type 2 diabetes and obesity.
- Other names
- GLP-1-Fc Fusion ProteinGLP1-Fc Fusion ProteinGLP 1-Fc Fusion ProteinGLP-1-FcGLP1-FcGLP 1-Fc
02
Targets
GLP1R (GLP-1R)FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)FCGRT (Neonatal crystallizable fragment receptor)
Beyond the preview
Go deeper on GLP-1 Fc fusion protein.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GLP-1 Fc fusion protein.